A Study to Evaluate EDP 938 Regimens in Children With RSV
Public ClinicalTrials.gov record NCT04816721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART STUDY TO EVALUATE EDP-938 REGIMENS IN SUBJECTS AGED 28 DAYS TO 36 MONTHS INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A 2-part study to evaluate the safety, pharmacokinetics and efficacy of EDP-938 in children with RSV infection.
Study identification
- NCT ID
- NCT04816721
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 28 Days to 36 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2022
- Primary completion
- Aug 18, 2024
- Completion
- Aug 18, 2024
- Last update posted
- Jul 27, 2025
2022 – 2024
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memorial Care Miller Children's and Women's Hospital | Long Beach | California | 90806 | — |
| University of California Los Angeles (UCLA) | Los Angeles | California | 90095 | — |
| University of California Davis | Sacramento | California | 95817 | — |
| Nemours Children's Hospital | Orlando | Florida | 32827 | — |
| South Tampa Center for Advanced Healthcare | Tampa | Florida | 33606 | — |
| Rexburg Pediatrics | Rexburg | Idaho | 83440 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Norton Children's Research Institute | Louisville | Kentucky | 40202 | — |
| MedPharmics - Lafayette | Lafayette | Louisiana | 70508 | — |
| LSU Health | Shreveport | Louisiana | 71101 | — |
| Willis-Knighton Health System | Shreveport | Louisiana | 71103 | — |
| Boston Children's Hospital - Division of Adolescent/Youth Adult Medicine | Boston | Massachusetts | 02115 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Le Bonheur Children's Hospital | Memphis | Tennessee | 38103 | — |
| Driscoll Children's Hospital | Corpus Christi | Texas | 78411 | — |
| Children's Health Specialty Center Dallas Campus | Dallas | Texas | 75207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04816721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04816721 live on ClinicalTrials.gov.